Hagop Kantarjian, MD of MD Anderson Cancer Center discusses Quizartinib FLT3 inhibitor status at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Hagop Kantarjian, MD of MD Anderson Cancer Center discusses Quizartinib FLT3 inhibitor status at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.